2026 Global: Artificial Dialysis Device Market -Competitive Review (2032) report
Description
The 2026 Global: Artificial Dialysis Device Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Fresenius Medical Care AG & Co. KGaA, headquartered in Bad Homburg vor der Höhe, Germany, dominates the global artificial dialysis device market through integrated patient care services and a comprehensive portfolio of dialysis machines and related equipment. Its manufacturing and service footprint spans clinics around the world, strengthening the reliability of the dialysis continuum for patients and providers alike. Baxter International Inc., based in Deerfield, Illinois, United States, remains a major force after its Gambro acquisition, expanding the Renal Care portfolio with dialysis machines, dialyzers, and disposables and reinforcing a global distribution and service network. B. Braun Melsungen AG, headquartered in Melsungen, Germany, contributes a broad line of hemodialysis devices and safety systems, benefiting from decades of medical device engineering and hospital supply integration. Nipro Corporation, headquartered in Osaka, Japan, offers dialysis machines, dialyzers, and tubing sets that span Asia and Europe, supporting large clinic networks and regional patient access.
Asahi Kasei Medical Co., Ltd., headquartered in Tokyo, Japan, is a leading innovator in dialysis technology, producing both compact dialysis machines and high-performance dialyzers. Its AK-series systems combine intuitive operation with precise fluid management, while its dialyzers emphasize biocompatibility and clearance efficiency. Nikkiso Co., Ltd., headquartered in Tokyo, Japan, is a diversified medical devices company with a growing dialysis portfolio that includes haemodialysis machines and related patient-care solutions designed for clinic efficiency and reliability. Terumo Corporation, headquartered in Tokyo, Japan, complements the market with a broad line of medical devices, including dialysis components, catheters, and integrated systems that support modern, patient-centered dialysis workflows. Toray Industries, Inc., headquartered in Tokyo, Japan, is a major membrane and materials supplier for the dialysis industry, providing hollow-fiber membranes and related polymers used by multiple manufacturers to produce dialyzers with improved biocompatibility and performance. Collectively, these suppliers enable ongoing innovation across devices and membranes globally.
Getinge AB, headquartered in Getinge, Sweden, supplies dialysis-related equipment, water-treatment systems, and clinical support services that enhance machine performance and workflow integration across clinics. Its offerings extend into critical-care solutions and sterilization technologies, underpinning end-to-end dialysis programs with service networks and remote monitoring capabilities. Kuraray Co., Ltd., headquartered in Tokyo, Japan, is a principal membrane materials supplier for dialyzers, contributing high-flux PES and biocompatible polymers that underpin modern, high-efficiency therapies. The collaboration among equipment manufacturers, membrane producers, and service providers sustains continuous improvement in treatment outcomes and patient experience. The artificial dialysis device market thus reflects a cross-border ecosystem where device engineering, material science, and logistics align to deliver reliable, scalable care. Ongoing investment in automation, data-driven monitoring, and advanced membrane chemistry will further consolidate leadership and spur new entrants through collaborative product development and regulatory-compliant innovation. Actionable partnerships and standardized trials will accelerate safe, effective dialysis worldwide for patients.
Fresenius Medical Care AG & Co. KGaA, headquartered in Bad Homburg vor der Höhe, Germany, dominates the global artificial dialysis device market through integrated patient care services and a comprehensive portfolio of dialysis machines and related equipment. Its manufacturing and service footprint spans clinics around the world, strengthening the reliability of the dialysis continuum for patients and providers alike. Baxter International Inc., based in Deerfield, Illinois, United States, remains a major force after its Gambro acquisition, expanding the Renal Care portfolio with dialysis machines, dialyzers, and disposables and reinforcing a global distribution and service network. B. Braun Melsungen AG, headquartered in Melsungen, Germany, contributes a broad line of hemodialysis devices and safety systems, benefiting from decades of medical device engineering and hospital supply integration. Nipro Corporation, headquartered in Osaka, Japan, offers dialysis machines, dialyzers, and tubing sets that span Asia and Europe, supporting large clinic networks and regional patient access.
Asahi Kasei Medical Co., Ltd., headquartered in Tokyo, Japan, is a leading innovator in dialysis technology, producing both compact dialysis machines and high-performance dialyzers. Its AK-series systems combine intuitive operation with precise fluid management, while its dialyzers emphasize biocompatibility and clearance efficiency. Nikkiso Co., Ltd., headquartered in Tokyo, Japan, is a diversified medical devices company with a growing dialysis portfolio that includes haemodialysis machines and related patient-care solutions designed for clinic efficiency and reliability. Terumo Corporation, headquartered in Tokyo, Japan, complements the market with a broad line of medical devices, including dialysis components, catheters, and integrated systems that support modern, patient-centered dialysis workflows. Toray Industries, Inc., headquartered in Tokyo, Japan, is a major membrane and materials supplier for the dialysis industry, providing hollow-fiber membranes and related polymers used by multiple manufacturers to produce dialyzers with improved biocompatibility and performance. Collectively, these suppliers enable ongoing innovation across devices and membranes globally.
Getinge AB, headquartered in Getinge, Sweden, supplies dialysis-related equipment, water-treatment systems, and clinical support services that enhance machine performance and workflow integration across clinics. Its offerings extend into critical-care solutions and sterilization technologies, underpinning end-to-end dialysis programs with service networks and remote monitoring capabilities. Kuraray Co., Ltd., headquartered in Tokyo, Japan, is a principal membrane materials supplier for dialyzers, contributing high-flux PES and biocompatible polymers that underpin modern, high-efficiency therapies. The collaboration among equipment manufacturers, membrane producers, and service providers sustains continuous improvement in treatment outcomes and patient experience. The artificial dialysis device market thus reflects a cross-border ecosystem where device engineering, material science, and logistics align to deliver reliable, scalable care. Ongoing investment in automation, data-driven monitoring, and advanced membrane chemistry will further consolidate leadership and spur new entrants through collaborative product development and regulatory-compliant innovation. Actionable partnerships and standardized trials will accelerate safe, effective dialysis worldwide for patients.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
